Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

114 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Three-year Follow up of GMCSF/bi-shRNA(furin) DNA-transfected Autologous Tumor Immunotherapy (Vigil) in Metastatic Advanced Ewing's Sarcoma.
Ghisoli M, Barve M, Mennel R, Lenarsky C, Horvath S, Wallraven G, Pappen BO, Whiting S, Rao D, Senzer N, Nemunaitis J. Ghisoli M, et al. Among authors: Senzer N. Mol Ther. 2016 Aug;24(8):1478-83. doi: 10.1038/mt.2016.86. Epub 2016 Apr 25. Mol Ther. 2016. PMID: 27109631 Free PMC article.
Phase II clinical trial of a granulocyte-macrophage colony-stimulating factor-encoding, second-generation oncolytic herpesvirus in patients with unresectable metastatic melanoma.
Senzer NN, Kaufman HL, Amatruda T, Nemunaitis M, Reid T, Daniels G, Gonzalez R, Glaspy J, Whitman E, Harrington K, Goldsweig H, Marshall T, Love C, Coffin R, Nemunaitis JJ. Senzer NN, et al. J Clin Oncol. 2009 Dec 1;27(34):5763-71. doi: 10.1200/JCO.2009.24.3675. Epub 2009 Nov 2. J Clin Oncol. 2009. PMID: 19884534 Clinical Trial.
Phase II trial of talabostat and docetaxel in advanced non-small cell lung cancer.
Eager RM, Cunningham CC, Senzer N, Richards DA, Raju RN, Jones B, Uprichard M, Nemunaitis J. Eager RM, et al. Clin Oncol (R Coll Radiol). 2009 Aug;21(6):464-72. doi: 10.1016/j.clon.2009.04.007. Epub 2009 Jun 5. Clin Oncol (R Coll Radiol). 2009. PMID: 19501491 Clinical Trial.
Vertically integrated translational studies of PDX1 as a therapeutic target for pancreatic cancer via a novel bifunctional RNAi platform.
Wu J, Liu S, Yu J, Zhou G, Rao D, Jay CM, Kumar P, Sanchez R, Templeton N, Senzer N, Maples P, Nemunaitis J, Brunicardi FC. Wu J, et al. Cancer Gene Ther. 2014 Feb;21(2):48-53. doi: 10.1038/cgt.2013.84. Epub 2014 Jan 24. Cancer Gene Ther. 2014. PMID: 24457987 Review.
Assessment of intravenous pbi-shRNA PDX1 nanoparticle (OFHIRNA-PDX1) in yucatan swine.
Jay CM, Ruoff C, Kumar P, Maass H, Spanhel B, Miller M, Arrington A, Montalvo N, Gresham V, Rao DD, Evans C, Wang Z, Brunicardi FC, Liu SH, Zhou G, Senzer N, Nemunaitis J, King L, Weeks B, Clubb FJ, Fossum TW, Maples PB. Jay CM, et al. Cancer Gene Ther. 2013 Dec;20(12):683-9. doi: 10.1038/cgt.2013.68. Epub 2013 Nov 29. Cancer Gene Ther. 2013. PMID: 24287722
Enhanced target gene knockdown by a bifunctional shRNA: a novel approach of RNA interference.
Rao DD, Maples PB, Senzer N, Kumar P, Wang Z, Pappen BO, Yu Y, Haddock C, Jay C, Phadke AP, Chen S, Kuhn J, Dylewski D, Scott S, Monsma D, Webb C, Tong A, Shanahan D, Nemunaitis J. Rao DD, et al. Cancer Gene Ther. 2010 Nov;17(11):780-91. doi: 10.1038/cgt.2010.35. Epub 2010 Jul 2. Cancer Gene Ther. 2010. PMID: 20596090
Phase II trial of Belagenpumatucel-L, a TGF-beta2 antisense gene modified allogeneic tumor vaccine in advanced non small cell lung cancer (NSCLC) patients.
Nemunaitis J, Nemunaitis M, Senzer N, Snitz P, Bedell C, Kumar P, Pappen B, Maples PB, Shawler D, Fakhrai H. Nemunaitis J, et al. Cancer Gene Ther. 2009 Aug;16(8):620-4. doi: 10.1038/cgt.2009.15. Epub 2009 Mar 13. Cancer Gene Ther. 2009. PMID: 19287371 Clinical Trial.
MicroRNA profile analysis of human prostate cancers.
Tong AW, Fulgham P, Jay C, Chen P, Khalil I, Liu S, Senzer N, Eklund AC, Han J, Nemunaitis J. Tong AW, et al. Cancer Gene Ther. 2009 Mar;16(3):206-16. doi: 10.1038/cgt.2008.77. Epub 2008 Oct 24. Cancer Gene Ther. 2009. PMID: 18949015
114 results
Jump to page